Literature DB >> 12927758

Absence of Chlamydia pneumoniae in brain of vascular dementia patients.

Matthew A Wozniak1, Ann Cookson, Gordon K Wilcock, Ruth F Itzhaki.   

Abstract

We recently detected cytomegalovirus (CMV) in brains of 83% of vascular dementia (VaD) patients and 34% of age-matched normal people. Since CMV and also Chlamydia pneumoniae (Cpn) have been found in some studies to be associated with coronary artery disease (which shares several risk factors with VaD), we sought Cpn DNA in VaD brain DNA. We examined brain specimens from 19 VaD patients, 16 elderly normal people and four Alzheimer's disease (AD) patients for the presence of a sequence in the Cpn gene for rRNA, using polymerase chain reaction (PCR) and taking stringent precautions against contamination. We did not detect Cpn DNA in any of the brain specimens, the sensitivity of detection being 10 copies or fewer bacterial DNA sequences per tube or, in terms of infectious units (IFU), 0.025 IFU. Our results do not support a role for Cpn in the aetiology of VaD, either in the 83% of patients in whose brains we detected CMV, or in the remaining 17% without CMV in brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927758     DOI: 10.1016/s0197-4580(02)00236-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

Review 1.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

3.  The association between self-reported tooth loss and cognitive function in the REasons for Geographic And Racial Differences in Stroke study: an assessment of potential pathways.

Authors:  Jonathan C Matthews; Zhiying You; Virginia G Wadley; Mary Cushman; George Howard
Journal:  J Am Dent Assoc       Date:  2011-04       Impact factor: 3.634

4.  Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia.

Authors:  Bogusław Paradowski; Malgorzata Jaremko; Tadeusz Dobosz; Jerzy Leszek; Leszek Noga
Journal:  J Neurol       Date:  2007-02-21       Impact factor: 4.849

Review 5.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

6.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

7.  Using animal models to determine the significance of complement activation in Alzheimer's disease.

Authors:  David A Loeffler
Journal:  J Neuroinflammation       Date:  2004-10-12       Impact factor: 8.322

8.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.